157 related articles for article (PubMed ID: 36307882)
1. Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development.
Wang ZL; Huang RY; Han B; Wu F; Sun ZY; Li GZ; Zhang W; Zhao Z; Liu X
Chin Neurosurg J; 2022 Oct; 8(1):34. PubMed ID: 36307882
[TBL] [Abstract][Full Text] [Related]
2. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.
Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D
Front Immunol; 2022; 13():773264. PubMed ID: 35185876
[TBL] [Abstract][Full Text] [Related]
3. Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma.
Zhou Q; Yan X; Zhu H; Xin Z; Zhao J; Shen W; Yin W; Guo Y; Xu H; Zhao M; Liu W; Jiang X; Ren C
Theranostics; 2021; 11(20):9775-9790. PubMed ID: 34815785
[No Abstract] [Full Text] [Related]
4. Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development.
Ma S; Ba Y; Ji H; Wang F; Du J; Hu S
Front Immunol; 2021; 12():738435. PubMed ID: 34603319
[TBL] [Abstract][Full Text] [Related]
5. Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development.
Wu C; Qin C; Long W; Wang X; Xiao K; Liu Q
J Big Data; 2022; 9(1):92. PubMed ID: 35855914
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of
Wang H; Wang X; Xu L; Zhang J; Cao H
Front Oncol; 2021; 11():551160. PubMed ID: 33959491
[No Abstract] [Full Text] [Related]
7. Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development.
Zhao Z; Xing N; Guo H; Li J; Sun G
Pharmgenomics Pers Med; 2024; 17():105-123. PubMed ID: 38623558
[TBL] [Abstract][Full Text] [Related]
8. Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development.
Ye L; Wang L; Yang J; Hu P; Zhang C; Tong S; Liu Z; Tian D
J Transl Med; 2021 Aug; 19(1):352. PubMed ID: 34404444
[TBL] [Abstract][Full Text] [Related]
9. Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development.
Ye L; Wang L; Yang J; Hu P; Zhang C; Tong S; Liu Z; Tian D
Front Genet; 2021; 12():701065. PubMed ID: 34527020
[No Abstract] [Full Text] [Related]
10. Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.
Zhong H; Liu S; Cao F; Zhao Y; Zhou J; Tang F; Peng Z; Li Y; Xu S; Wang C; Yang G; Li ZQ
Front Immunol; 2021; 12():709986. PubMed ID: 34512630
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy.
Li G; Wu Z; Gu J; Zhu Y; Zhang T; Wang F; Huang K; Gu C; Xu K; Zhan R; Shen J
Front Cell Dev Biol; 2021; 9():755776. PubMed ID: 34888308
[TBL] [Abstract][Full Text] [Related]
12. Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development.
Chen Z; Wang X; Yan Z; Zhang M
Cancer Med; 2022 Jul; 11(13):2711-2726. PubMed ID: 35285582
[TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
14. Identification of Gender-Specific Molecular Differences in Glioblastoma (GBM) and Low-Grade Glioma (LGG) by the Analysis of Large Transcriptomic and Epigenomic Datasets.
Khan MT; Prajapati B; Lakhina S; Sharma M; Prajapati S; Chosdol K; Sinha S
Front Oncol; 2021; 11():699594. PubMed ID: 34621669
[TBL] [Abstract][Full Text] [Related]
15. Low expression of CDHR1 is an independent unfavorable prognostic factor in glioma.
Wang H; Wang X; Xu L; Lin Y; Zhang J; Cao H
J Cancer; 2021; 12(17):5193-5205. PubMed ID: 34335936
[No Abstract] [Full Text] [Related]
16. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
18. Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development.
Lu TL; Li CL; Gong YQ; Hou FT; Chen CW
World J Gastrointest Oncol; 2023 Oct; 15(10):1717-1738. PubMed ID: 37969406
[TBL] [Abstract][Full Text] [Related]
19. Chromobox 7/8 serve as independent indicators for glioblastoma
Zheng ZQ; Yuan GQ; Kang NL; Nie QQ; Zhang GG; Wang Z
Front Neurol; 2022; 13():912039. PubMed ID: 36034290
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination.
You W; Ouyang J; Cai Z; Chen Y; Wu X
Front Immunol; 2022; 13():827506. PubMed ID: 35874675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
